HOME >> BIOLOGY >> NEWS
First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely

The first rigorous study of the dietary supplement resveratrol found that oral dietary supplements of resveratrol are unlikely to have any effect on breast and prostate cancer.

Dr. Thomas Walle, Medical University of South Carolina, presented the results at Experimental Biology 2004, as part of the scientific sessions of the American Society of Pharmacology and Experimental Therapeutics.

Resveratrol, a plant antioxidant found in abundance in grapes, wine, and peanuts, is widely sold as a dietary supplement with claims of numerous beneficial health effects. These range from extending life spans to preventing heart disease and cancer. However, these positive health effects have mainly been shown in cultured cells, and it has been unclear if resveratrol can reach the circulating blood in sufficient amounts to have therapeutic effects.

In the study by Dr. Walle and research associate Kristina Walle, C-14-Tagged resveratrol was administered both by mouth and intravenously to healthy volunteers. The researchers found that resveratrol (25-mg doses) is very well absorbed after oral dosing with most of the dose appearing in the urine in the first 12 hours. However, the urine contained resveratrol only as sulfate and glucuronic acid conjugates, none as the free, presumably active, form.

Likewise, the only blood samples containing free resveratrol were those drawn within 30 minutes after the intravenous injection. No free resveratrol was present in blood samples drawn after oral doses.

Based on this study's findings, Dr. Walle ways it would seem highly unlikely that resveratrol per se can have any effect on cardiovascular disease or cancer of such organs as the breast or prostate gland when consumed in the diet or as a dietary supplement.

However, he adds, it is still possible that orally administered resveratrol can prevent cancers along the aerodigestive tract. It is also possible that a resveratrol sulfate conjugate detected
'"/>

Contact: Sarah Goodwin
eb4press@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
19-Apr-2004


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... (PRWEB) , ... August 30, 2018 , ... CallTower ... Success. Jason has more than 20-years of telecommunications experience and over ten years in ... Communications, which was acquired by CallTower in early 2018. , In this new ...
(Date:8/31/2018)... ... August 30, 2018 , ... USDM Life Sciences , ... sciences and healthcare industries, has received the 2018 Services Partner of the Year, Awarded ... by Box SVP of Business Development and Platform Sales, Niall Wall and received by ...
(Date:8/29/2018)... Calif. (PRWEB) , ... August ... ... Dx”), a radiopharmaceutical company unlocking the full power of positron emission tomography ... alkali metal catalysis, Fuzionaire Dx is helping clinicians and researchers study and ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... Calif. (PRWEB) , ... September 05, 2018 , ... Now ... Park Systems will be held on Sept. 19, 2018. With a panel of industry ... SPM, this exciting event will reveal industry insights from experts in the field. ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced ... career as an executive and leader of numerous biotech companies. , He most ... biologics company acquired by Thompson Street Capital in St. Louis, MO. Prior to ...
(Date:8/29/2018)... , ... August 28, 2018 , ... ... enhanced spinal implants, announced today the successful completion of a $5.5 million funding ... Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. , “Our investment ...
(Date:8/29/2018)... ... August 28, 2018 , ... LabRoots , the leading provider of interactive ... to announce the launch of a new gamification feature, allowing users to earn points ... of LabRoots most popular shirts. , Throughout each month, LabRoots users will earn points ...
Breaking Biology Technology:
Cached News: